Press Releases

April 6, 2020

PharmaCielo Ltd. Prices $8 Million Offering; Closing Scheduled for April 14

Read more
April 6, 2020

PharmaCielo Adjusts Operations to Support Colombian Government’s COVID-19 Mitigation Efforts

Read more
April 1, 2020

PharmaCielo Ltd. Announces Best Efforts Private Placement Offering

Read more
March 23, 2020

PharmaCielo Independent Investigation Concludes Short Seller Report Contains Accusations and Claims Based on Faulty Interpretation of Events and Information

Read more
March 3, 2020

PharmaCielo Issues Statement Regarding Misleading Short Seller Report

Read more
January 27, 2020

PharmaCielo Announces 30,000 Kg Cannabis Extract Agreement for German Market

Read more
January 24, 2020

PharmaCielo Signs Pan-European Distribution Agreement for CBD Isolate and Broad-Spectrum CBD Oil

Read more
January 22, 2020

PharmaCielo Added to XCAN – the Newly Created S&P/TSX Cannabis Index

Read more
January 20, 2020

PharmaCielo Becomes First Cultivator Awarded Good Agricultural Practices (GAP) Global Certification for Colombian Medicinal-Cannabis Operations

Read more
January 17, 2020

PharmaCielo Receives Acceptance from TSX Venture Exchange of Supply Agreement for Export of 2018 Farm Bill Compliant CBD Isolate to United States

Read more
Back to Company News & Media Coverage